The research network, EUROME, represents Centers of Excellence in Europe where recent technologies in transcriptome (microarrays) as well as proteome analysis are applied to study with the use of transgenic and congenic animal models human autoimmune diseases primarily rheumatoid arthritis (RA). Susceptibility genes for autoimmune diseases are identified and their functions are determined. Targets for studying novel treatments are evaluated i.e. to stop neoangiogenesis in inflamed tissues. Gene and cell based intervention strategies are investigated to treat autoimmune diseases (rheumatoid arthritis). Common mechanisms that cause autoimmune diseases are determined. EUROM research leads to a genome-base individualized medicine.
Funding SchemeCSC - Cost-sharing contracts
16672 Glyfada (Attiki)
W6 8LH London
221 84 Lund